BR0318498A - composições terapêuticas à base de porìfero para o tratamento e a prevenção de doenças da pele - Google Patents

composições terapêuticas à base de porìfero para o tratamento e a prevenção de doenças da pele

Info

Publication number
BR0318498A
BR0318498A BRPI0318498-6A BR0318498A BR0318498A BR 0318498 A BR0318498 A BR 0318498A BR 0318498 A BR0318498 A BR 0318498A BR 0318498 A BR0318498 A BR 0318498A
Authority
BR
Brazil
Prior art keywords
therapeutic compositions
prevention
treatment
diseases
porphore
Prior art date
Application number
BRPI0318498-6A
Other languages
English (en)
Other versions
BRPI0318498B1 (pt
Inventor
Maria Villani
Original Assignee
Maria Villani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maria Villani filed Critical Maria Villani
Publication of BR0318498A publication Critical patent/BR0318498A/pt
Publication of BRPI0318498B1 publication Critical patent/BRPI0318498B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/22—Boron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/655—Aquatic animals other than those covered by groups A61K35/57 - A61K35/65
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Oceanography (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"COMPOSIçõES TERAPêUTICAS à BASE DE PORìFERO PARA O TRATAMENTO E A PREVENçãO DE DOENçAS DA PELE". Composições terapêuticas e métodos para a sua utilização para o tratamento de condições e doenças da pele são divulgados. As condições e as doenças da pele tratáveis incluem, sem limitação, a acne vulgar, a rosácea, a dermatite seborréica, o eczema (dermatite atópica) , a psoríase, o foto-envelhecimento e a ceratose actínica, a acne vulgar, a psoríase, o foto-envelhecimento e o eczema. As composições terapêuticas divulgadas são derivadas da espécie de Porífero, especificamente as esponjas, e mais especificamente as esponjas de água doce. Uma modalidade divulgada é derivada da espécie Spongilla e é formulada com excipientes farmaceuticamente aceitáveis.
BRPI0318498A 2002-07-01 2003-09-09 composições terapêuticas à base de porifera para o tratamento e a prevenção de doenças da pele BRPI0318498B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18699602A 2002-07-01 2002-07-01
PCT/US2003/028188 WO2005034839A2 (en) 2002-07-01 2003-09-09 Porifera-based therapeutic compositions for treating and preventing skin diseases

Publications (2)

Publication Number Publication Date
BR0318498A true BR0318498A (pt) 2006-09-12
BRPI0318498B1 BRPI0318498B1 (pt) 2016-07-05

Family

ID=47724660

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0318498A BRPI0318498B1 (pt) 2002-07-01 2003-09-09 composições terapêuticas à base de porifera para o tratamento e a prevenção de doenças da pele

Country Status (8)

Country Link
US (2) US7604821B2 (pt)
EP (1) EP1663104B1 (pt)
JP (1) JP4889093B2 (pt)
KR (1) KR101183075B1 (pt)
AU (1) AU2003278775B2 (pt)
BR (1) BRPI0318498B1 (pt)
CA (1) CA2538093C (pt)
WO (1) WO2005034839A2 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130309315A1 (en) * 2002-07-01 2013-11-21 Maria Villani Porifera-based therapeutic compositions for treating and preventing skin diseases
US7604821B2 (en) 2002-07-01 2009-10-20 Maria Villani Porifera-based therapeutic compositions for treating and preventing skin diseases
ITUD20050211A1 (it) * 2005-12-13 2007-06-14 Rossana Castellana Prodotto per il trattamento della pelle relativo procedimento di preparazione
CA2678083A1 (en) * 2006-01-24 2007-08-02 Patricia J. Hill Compositions and methods for treatment of dermal scarring and wrinkling
EP1993569B1 (en) * 2006-02-03 2014-07-23 OMP, Inc. Anti-aging treatment using copper and zinc compositions
US7897800B2 (en) * 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7876258B2 (en) * 2006-03-13 2011-01-25 The Boeing Company Aircraft collision sense and avoidance system and method
DE202006020459U1 (de) * 2006-08-16 2008-08-07 Lohmann & Rauscher Gmbh & Co. Kg Zubereitung mit marinem Kollagen zur Proteinasehemmung
KR20090087877A (ko) * 2006-10-05 2009-08-18 마리아 빌라니 피부 연마 기구 또는 피부 재생 수단으로서의 스폰질라 골편의 용도
US20130085957A1 (en) * 2011-09-30 2013-04-04 Precision Dermatology, Inc. Method and system for automatic product replenishment
EP2863893A4 (en) * 2012-06-22 2015-07-01 Univ Queensland METHOD AND COMPOSITION FOR DELIVERING COMPOUND THROUGH A BIOLOGICAL BARRIER
JP2014028765A (ja) * 2012-07-31 2014-02-13 Shigeo Tanaka 育毛または発毛のためのマッサージ用塗布材
EP3177365A4 (en) * 2014-08-06 2018-01-10 Thesan Pharmaceuticals, Inc. Agonists of the ahr receptor pathway having sebosuppressive activity and a method for identifying said agonists
KR101676796B1 (ko) 2015-03-25 2016-11-16 제너럴바이오(주) 침상 구조를 갖는 해면 파우더의 제조방법 및 이로부터 제조된 침상 구조를 갖는 해면 파우더
CN105999535A (zh) 2016-04-27 2016-10-12 厦门大学 海绵骨针作为皮肤物理促渗剂的应用
CN106166326A (zh) * 2016-08-19 2016-11-30 王子元 一种非介入导入方法
KR101865764B1 (ko) * 2017-01-13 2018-06-11 주식회사 아미코스메틱 천연 복합 추출물 및 미세침 분말을 유효성분으로 포함하는 각질 박리용 화장료 조성물
KR101908408B1 (ko) * 2017-01-13 2018-10-16 주식회사 아미코스메틱 미세침 분말 및 천연 분말을 유효성분으로 포함하는 각질 박리용 화장료 조성물
CN109381422B (zh) 2017-08-07 2020-11-06 厦门大学 一种经皮吸收组合物及其在制备经皮吸收制剂中的用途
CA3142077A1 (en) * 2018-06-13 2019-12-19 Dermata Therapeutics, Llc Compositions for the treatment of skin conditions
KR102113645B1 (ko) * 2018-08-01 2020-05-22 주식회사 아미코스메틱 미세침 분말 및 천연 추출물을 유효성분으로 포함하는 탈모 방지 및 모발 성장 촉진용 화장료 조성물
US20210337842A1 (en) * 2018-10-11 2021-11-04 Cargill, Incorporated Seaweed flour
CN109288734B (zh) * 2018-11-30 2021-09-03 广州市科能化妆品科研有限公司 免洗海藻油卸妆膏及其制备方法
JP2022510377A (ja) * 2018-12-03 2022-01-26 デルマタ・セラピューティクス，エルエルシー 状態の処置のための組成物
KR102037030B1 (ko) 2019-05-14 2019-11-26 오영진 피토실리카(Phytosilica)를 함유하는 여드름 개선용 화장료 조성물
WO2021016118A1 (en) * 2019-07-23 2021-01-28 Dermata Therapeutics, Llc Compositions for the treatment of conditions by dermal fillers
CN111249306A (zh) * 2020-01-16 2020-06-09 刘贤贤 一种去除角质的药物及其制备方法
CN114099761B (zh) * 2020-08-27 2022-06-21 厦门大学 一种浴海绵止血材料及其制备方法和应用
WO2024151612A1 (en) 2023-01-13 2024-07-18 Dermata Therapeutics, Inc. Compositions for inducing immune responses

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896238A (en) * 1972-04-05 1975-07-22 Procter & Gamble Dermatological compositions
GB2068225B (en) * 1980-06-09 1983-12-14 Quinodern Ltd Dermatological compositions containing hydrogen peroxide
AU7956482A (en) * 1981-01-30 1982-08-05 Key Pharmaceuticals, Inc. Lecithin-hydrogen peroxide composition
US5196185A (en) * 1989-09-11 1993-03-23 Micro-Collagen Pharmaceutics, Ltd. Collagen-based wound dressing and method for applying same
US5139771A (en) * 1990-04-16 1992-08-18 Revlon, Inc. Rinse away face masque
DE4028622C2 (de) * 1990-09-08 1994-01-27 Suwelack Nachf Dr Otto Verfahren zum Herstellen von Kollagenschwämmen
CA2033107C (en) * 1990-12-24 2001-06-12 Robert Edward Burrell Actively sterile surfaces
BR9205713A (pt) * 1991-03-01 1994-06-07 Atherton Investments Ltd Ingrediente ativo de secreçao de gastrópode, processo para sua preparaçao, e composiçao de ingrediente ativo
JPH06107520A (ja) * 1992-09-25 1994-04-19 Idemitsu Petrochem Co Ltd 化粧料
RU2038070C1 (ru) 1992-10-28 1995-06-27 Елена Юрьевна Хараламбус Набор масок для лечения косметических недостатков кожи
CN1096205A (zh) 1993-06-07 1994-12-14 赵志国 延衰营养口服液
CA2204777A1 (en) * 1994-11-15 1996-05-23 Steven Scott Porter Skin care compositions and methods
CN1152455A (zh) 1995-12-18 1997-06-25 李志恒 一种阳痿、早泄敷脐治疗带
US6218345B1 (en) * 1996-07-03 2001-04-17 The Procter & Gamble Company Cleansing compositions
US5736582A (en) * 1996-10-10 1998-04-07 Devillez; Richard L. Method and composition for controlled delivery of nascent oxygen from hydrogen peroxide source for skin treatment
US5741482A (en) * 1996-11-06 1998-04-21 Hercules Incorporated Air treatment gel compositions
US5869062A (en) * 1997-05-27 1999-02-09 Oliver; Benjamin Skin treatment composition
US6136329A (en) * 1997-06-04 2000-10-24 Boratyn; Diane C. Compositions and methods relating to intra-lamellar gels from algae
US6312678B1 (en) * 1997-08-22 2001-11-06 The Procter & Gamble Company Cleansing compositions comprising water-soluble surfactant and water-insoluble oil
US6106818A (en) * 1998-04-27 2000-08-22 Revlon Consumer Products Corporation Method for removing dead surface cells, dirt, oil, and blackheads from the skin and related compositions and articles
JP3094090B2 (ja) * 1998-06-01 2000-10-03 憲司 中村 海綿動物タンパク質加水分解物及びその製造方法
FR2801314B1 (fr) * 1999-05-19 2002-05-10 Coletica Produit collagenique contenant du collagene d'origine marine a faible odeur et a proprietes mecaniques ameliorees, ainsi que son utilisation sous forme de compositions ou de produits cosmetiques ou pharmaceutiques
US6352685B2 (en) * 1999-12-24 2002-03-05 KOSé CORPORATION External preparation for skin
DE10010113B4 (de) * 2000-03-03 2009-05-07 Wolfgang Dr. Schatton Natives Schwammkollagen, Verfahren zu seiner Isolierung und seine Verwendung, sowie natives nanopartikuläres Schwammkollagen, Verfahren zu seiner Herstellung und seine Verwendung
RU2160089C1 (ru) 2000-03-14 2000-12-10 Гройсман Валентина Михайловна Мазь для лечения заболеваний кожи
JP2002087925A (ja) * 2000-09-13 2002-03-27 Kenji Nakamura 皮膚外用剤
US6821264B1 (en) * 2000-11-27 2004-11-23 Gautam Khurana Gene delivery device and gene delivery method
RU2176511C1 (ru) * 2001-02-19 2001-12-10 Закрытое акционерное общество "Коммерческий центр "НИЗАР" Средство для профилактики угревой болезни и способ его получения
FR2821551B1 (fr) * 2001-03-05 2004-05-14 Oreal Utilisations de derives de polyaminoacides comme agents hydratants, et compositions cosmetiques ou pharmaceutiques les comprenant
RU2183967C1 (ru) * 2001-08-08 2002-06-27 Закрытое акционерное общество "Коммерческий центр "НИЗАР" Способ лечения целлюлита
RU2182820C1 (ru) * 2001-10-01 2002-05-27 Закрытое акционерное общество "Коммерческий центр "НИЗАР" Стимулирующий косметический крем
RU2182821C1 (ru) 2001-10-01 2002-05-27 Закрытое акционерное общество "Коммерческий центр "НИЗАР" Массажный крем
US7604821B2 (en) * 2002-07-01 2009-10-20 Maria Villani Porifera-based therapeutic compositions for treating and preventing skin diseases
JP2004250357A (ja) * 2003-02-19 2004-09-09 Kenji Nakamura スキンケア外用剤

Also Published As

Publication number Publication date
AU2003278775B2 (en) 2010-06-17
JP2007521238A (ja) 2007-08-02
AU2003278775A8 (en) 2005-04-27
BRPI0318498B1 (pt) 2016-07-05
AU2003278775A1 (en) 2005-04-27
EP1663104A4 (en) 2007-05-16
CA2538093C (en) 2015-06-02
JP4889093B2 (ja) 2012-02-29
US20040109872A1 (en) 2004-06-10
US20100297095A1 (en) 2010-11-25
WO2005034839A3 (en) 2005-09-01
US8383100B2 (en) 2013-02-26
US7604821B2 (en) 2009-10-20
KR101183075B1 (ko) 2012-09-20
WO2005034839A2 (en) 2005-04-21
KR20060097013A (ko) 2006-09-13
EP1663104A2 (en) 2006-06-07
EP1663104B1 (en) 2014-02-12
CA2538093A1 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
BR0318498A (pt) composições terapêuticas à base de porìfero para o tratamento e a prevenção de doenças da pele
ECSP055844A (es) Nuevos compuestos triciclicos
GB0225475D0 (en) Therapeutic agents
GB0318447D0 (en) Therapeutic agents
BR0207663A (pt) Uso de inibidores de egfr naturais para prevenir os efeitos colaterais devido à terapia com retinóides, sabões e outros estìmulos que ativam o receptor do fator de crescimento epidérmico
GB0223038D0 (en) Therapeutic compounds
NO20051262L (no) Anvendelse av CGRP-antagonistforbindelser for behandling av psoriasis
BRPI0408063A (pt) métodos e composições envolvendo mda-7
GB0225474D0 (en) Therapeutic agents
DE60209504D1 (de) Carbocyclische hydrazino-hemmer von kupferhaltigen aminoxidasen
HK1079446A1 (en) Pharmeceutical solid dispersions of modafinil compounds
BR0315597A (pt) Processos de baixa dose para tratamento de distúrbios em que a atividade de tnf(alfa)é prejudicial
EA200500250A1 (ru) Аналоги тиомолибдата и их применение
NO20050718L (no) Topikal behandling av hudsykdommer
WO2008020027A3 (en) 2,5-dihydroxybenzene compounds for the treatment of skin cancer
BRPI0512253A (pt) composto, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
WO2003106381A3 (en) ADAM 10 HUMAN INHIBITORS
ECSP034518A (es) Nuevos retinoides para el tratamiento de enfisema
BR0312845A (pt) Tetratiomolibdato de tetrapropilamÈnio e compostos relacionados para terapias antiangiogênicas
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
WO2005027977A3 (en) Diclofenac compositions for the treatment of skin disorders
BR0313718A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica, métodos para tratar um indivìduo humano ou animal sofrendo de uma condição que é mediada por cox-2 e para tratar um indivìduo humano ou animal sofrendo de um distúrbio inflamatório, e, uso de um composto
EP1281399A3 (en) Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
CY1111353T1 (el) Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: AS CLASSIFICACOES ANTERIORES ERAM: A61K 6/00 , A61K 7/00 , A61K 7/42 , A61K 31/74 , A61K 39/00 , A61K 39/38

Ipc: A61K 31/40 (2006.01), A61K 35/56 (2006.01), A61K 3

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B08E Application fees: payment of additional fee required [chapter 8.5 patent gazette]

Free format text: COMPLEMENTAR 11A. ANUIDADE(S) DE ACORDO COM TABELA VIGENTE REFERENTE A(S) GUIA(S) 92140019221-7.

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/07/2016, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time
B24D Patent annual fee: restoration after fee payment